Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact
Lead Discovery, Oct 2004, Pages: 59

  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  
Enquire before Buying
To contact our Customer Service Team complete all fields below and click on "Send". We aim to respond to all enquiries on the same business day.

 * Required Information
Your Question
  Enquiry Subject *

Your Question *
Your Contact Details
  Your Title *
                  
First Name *       Last Name *

 
  
 

Email Address *

 

Country *
 
Phone Number *
 
You will be emailed a special link to our Customer Service Enquiry System to track your reply. To make sure that Research and Markets customer support emails reach your inbox and are not filtered into your "junk" or "bulk" folder, please whitelist our email domain which is @researchandmarkets.net
 



Customers who bought this item also bought

COX-2 Inhibitors - Biology, Therapeutic Agents & Markets

Vioxx Recall - Revenue Analysis and Impact on Cox-2 Inhibitor Markets

Event Analysis and Response Service: Cox-2s - Cox-2 Crisis Dents Big Pharma Confidence

The Vioxx Withdrawal: Changes and Opportunities for the Industry

Drug Safety in the Post-Vioxx Era: New Legislation, Regulation and Company Strategies in Europe and the US

The Future of Cox-ii Inhibitors: Market Challenges and Pipeline Initiatives

Global market size for arthritis medications by number of prescriptions and by sales in US dollars, with breakout of sales and percent market share for Celebrex / Valdecoxib and Vioxx / Etoricoxib coxib ( COX-2 specific inhibitor ) drugs in 2000 fore

US VIOXX Litigation Update Call - Merck & Co., Inc. - Earnings Transcript

Sales of Cox-2 Inhibitors, 1999-2004

The Global Pain Therapeutics Market, 3rd Edition - Market Analysis, R&D Pipelines and Competitive Landscape

Competitor Analysis: HDAC Inhibitors

Competitor Analysis: PARP Inhibitors
Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds